Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX1 | P51575 | 9/20 | 0.76 |
| ▸ | P2RX4 | Q99571 | 5/20 | 0.76 |
| ▸ | P2RX7 | Q99572 | 5/20 | 0.76 |
| ▸ | TMPRSS4 | Q9NRS4 | 5/20 | 0.76 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.64 |
| ▸ | PLAU | P00749 | 2/20 | 0.62 |
| ▸ | F2 | P00734 | 1/20 | 0.62 |
| ▸ | F10 | P00742 | 1/20 | 0.62 |
| ▸ | PLG | P00747 | 1/20 | 0.62 |
| ▸ | PLAT | P00750 | 1/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | FADS1 | O60427 | 2/20 | 0.58 |
| ▸ | PNLIP | P16233 | 1/20 | 0.57 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | IKBKB | O14920 | 1/20 | 0.52 |
| ▸ | CHUK | O15111 | 1/20 | 0.52 |
| ▸ | KDR | P35968 | 1/20 | 0.52 |
| ▸ | FLT3 | P36888 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL332057 | 0.86 | P2RX1 (1.00) | P2RX1P2RX4P2RX7TMPRSS4KCNMA1 | |
| SCHEMBL25348257 | 0.86 | KLKB1 (0.64) | P2RX1P2RX4P2RX7TMPRSS4KLKB1 | |
| SCHEMBL7172686 | 0.85 | TMPRSS4 (0.77) | P2RX1P2RX4P2RX7TMPRSS4KLKB1 | |
| SCHEMBL25351007 | 0.84 | P2RX1 (0.62) | P2RX1P2RX4P2RX7TMPRSS4KLKB1 | |
| SCHEMBL330755 | 0.83 | FADS1 (0.77) | P2RX1P2RX4P2RX7TMPRSS4ALOX15 | |
| SCHEMBL18290067 | 0.82 | PNLIP (0.67) | P2RX1P2RX4P2RX7TMPRSS4KLKB1 | |
| SCHEMBL23303864 | 0.82 | P2RX1 (0.71) | P2RX1P2RX4P2RX7TMPRSS4MEN1 | |
| SCHEMBL130143 | 0.82 | P2RX1 (1.00) | P2RX1P2RX4P2RX7TMPRSS4KLKB1 | |
| SCHEMBL330715 | 0.79 | TMPRSS4 (0.65) | P2RX1P2RX4P2RX7TMPRSS4PLAU | |
| SCHEMBL25349155 | 0.79 | TMPRSS4 (0.80) | P2RX1P2RX4P2RX7TMPRSS4KLKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8097759-B2 | Inflammatory cytokine release inhibitor | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2012-01-17 | — | — | US | disclosed |
| US-20100274051-A1 | INFLAMMATORY CYTOKINE RELEASE INHIBITOR | INSTITUTE OF MEDICINAL MOLECULAR DESIGN. INC. (JP) | 2010-10-28 | — | — | US | disclosed |
| US-20090192122-A2 | INFLAMMATORY CYTOKINE RELEASE INHIBITOR | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2009-07-30 | — | — | US | disclosed |
| US-20080318956-A1 | INFLAMMATORY CYTOKINE RELEASE INHIBITOR | INSTITUTE OF MEDICINAL MOLECULAR DESIGN. INC. (JP) | 2008-12-25 | — | — | US | disclosed |
| US-20080249071-A1 | INFLAMMATORY CYTOKINE RELEASE INHIBITOR | INSTITUTE OF MEDICINAL MOLECULAR DESIGN. INC. (JP) | 2008-10-09 | — | — | US | disclosed |
| EP-1847263-A2 | Inhibitors against the production and release of inflammatory cytokines | Institute of Medicinal Molecular Design, Inc. (JP) | 2007-10-24 | — | — | EP | disclosed |
| EP-1844766-A2 | Inhibitors against the production and release of inflammatory cytokines | Institute of Medicinal Molecular Design, Inc. (JP) | 2007-10-17 | — | — | EP | disclosed |
| EP-1352650-A1 | INHIBITORS AGAINST THE PRODUCTION AND RELEASE OF INFLAMMATORY CYTOKINES | Institute of Medicinal Molecular Design, Inc. (JP) | 2003-10-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100274051-A1 | INFLAMMATORY CYTOKINE RELEASE INHIBITOR | IL1B, NFKBIA, IL1A | P2RX1 1459/4885P2RX4 2669/4885P2RX7 928/4885 |
| US-20090192122-A2 | INFLAMMATORY CYTOKINE RELEASE INHIBITOR | IL1B, NFKBIA, IL1A | P2RX1 1538/4885P2RX4 2695/4885P2RX7 973/4885 |
| US-20080249071-A1 | INFLAMMATORY CYTOKINE RELEASE INHIBITOR | IL1B, NFKBIA, IL1A | P2RX1 1538/4885P2RX4 2695/4885P2RX7 973/4885 |
| US-20080318956-A1 | INFLAMMATORY CYTOKINE RELEASE INHIBITOR | IL1B, NFKBIA, IL1A | P2RX1 1538/4885P2RX4 2695/4885P2RX7 973/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.